Publications → Themes → 03
Diabetes
Real-world safety and utilisation of diabetes drugs in Asian populations — from the second PSSA on thiazolidinediones through current GLP-1 and 5α-reductase × T2DM studies where the underlying epidemiology often differs from Western trial cohorts.
5 papers · 2018–2026
- 2026 · Clinical Pharmacology & Therapeutics
Emulating six cardiovascular outcome trials of antidiabetic drugs using real-world databases from Korea and Taiwan
Ko HY, Au PCM, Cheng MC, Cheung CL, Choi A, Hsieh MH, ..., Shin JY, Park S.
- 2025 · Thyroid
Glucagon-like peptide 1 receptor agonists and thyroid cancer risk: an international multisite cohort study
Baxter SM, Lund LC, Andersen JH, Brix TH, Hegedus L, Hsieh MH, ..., Hicks B, Pottegard A.
- 2025 · Diabetes Care
Risk of thyroid tumors with GLP-1 receptor agonists: a retrospective cohort study
Morales DR, Bu F, Viernes B, DuVall SL, Matheny ME, Simon KR, ..., Khera R, Suchard MA.
- 2019 · BMJ
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
Wei L, Lai ECC, Kao-Yang YH, Walker BR, MacDonald TM, Andrew R.
- 2018 · PLoS One
Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study
Kubota K, Kamijima Y, Kao Yang YH, Kimura S, Chia-Cheng Lai E, Man KKC, ..., Zhang Y, Setoguchi S.
antidiabeticdrug utilizationmultinational 📄 Full text DOI: 10.1371/journal.pone.0208796 PMID: 30540837